ERCP as an outpatient treatment: a review.
BACKGROUND
ERCP on an outpatient basis could be as safe as on an inpatient basis and may also reduce medical costs.


OBJECTIVE
To review the available literature to determine the safety of an ERCP performed on an outpatient basis.


METHODS
A review of the published literature was performed by searching PubMed, the Cochrane Library, EMBASE, and the Web of Science.


METHODS
Patients who were undergoing an ERCP.


METHODS
An ERCP on an inpatient or outpatient basis.


METHODS
Patient and treatment characteristics, complications, and prolonged hospital admissions and readmissions.


RESULTS
Eleven studies were included in this review, of which 5 were comparative studies, 5 were prospective studies, and 1 was a retrospective study. In these series, a total of 2483 patients underwent an ERCP on an outpatient basis and 2320 patients were admitted overnight after an ERCP. Complications were seen in 184 of 2483 outpatients (7%), of which 72% of complications (107/149) presented within 2 to 6 hours, 10% (15/149) within 6 to 24 hours, and 18% (27/149) more than 24 hours after the ERCP. Three percent of the inpatients (82/2320) developed a complication, of which 95% of complications (78/82) presented within 24 hours and 5% (4/82) presented more than 24 hours after the ERCP. A prolonged hospital stay after an ERCP was indicated in 6% of the designated outpatients (148/2483), whereas 3% of outpatients (74/2149) and <1% of inpatients (4/2320) were readmitted after discharge.


CONCLUSIONS
Limited data available.


CONCLUSIONS
This review shows that, with a selective policy, an ERCP on an outpatient basis seems as safe as when performed on an inpatient basis.
Jeurnink
Suzanne M
SM
Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center, Rotterdam, The Netherlands.
Poley
Jan Werner
JW
Steyerberg
Ewout W
EW
Kuipers
Ernst J
EJ
Siersema
Peter D
PD
D000368:Aged; D000553:Ambulatory Care / Q000191:economics / Q000379:methods*; D000556:Ambulatory Surgical Procedures / Q000009:adverse effects / Q000191:economics / Q000379:methods; D001660:Biliary Tract Diseases / Q000175:diagnosis / Q000601:surgery; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004502:Education, Medical, Continuing; D005260:Female; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D010182:Pancreatic Diseases / Q000175:diagnosis / Q000601:surgery; D018570:Risk Assessment; D012449:Safety; D012680:Sensitivity and Specificity